AUBAGIO (teriflunomide): Reviews and patient testimonials
Medication indications
AUBAGIO 14 mg film-coated tablets
AUBAGIO is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (MS).
(please refer to section 5.1 for important information on the population for which efficacy has been established).
Route of administration: Oral
Molecule: teriflunomide
Patients' opinions on AUBAGIO
In brief
General satisfaction level: 8.67/10 Learn more
Treatment's effectiveness: 7.67/10 Learn more
Ease of use: 10.00/10 Learn more
Adherence to prescription: 10.00/10 Learn more
Detected side effects: 3.00/10 Learn more
Improvement in the quality of life: 7.00/10 Learn more
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community